Med-Tech Innovation January 24, 2024

Olympus, has closed the acquisition of Taewoong Medical, a Korea-based manufacturer of medical devices such as gastrointestinal (GI) metallic stents.

Taewoong Medical will join Olympus as a subsidiary, enabling Olympus to strengthen its GI EndoTherapy product portfolio capabilities, contribute to improving patient outcomes through comprehensive solutions, and elevate the standard of care.

Taewoong Medical offers medical devices including metallic stents designed for biliary tract, oesophagus, colon, and duodenum treatments. With the closing of the transaction, which was first proposed and announced in February 2023, Olympus will immediately oversee its offices and operations in Korea. Taewoong Medical will join Olympus’ Therapeutic Solutions Division, helping Olympus become a solutions provider in the GI market with varied GI EndoTherapy solutions by bringing together...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies
Boston Scientific to acquire SoniVie for $540 million, expand hypertension treatment portfolio
Medicare Coverage Of Medical Technologies In A New Era
This year's top congressional medical technology priorities

Share This Article